Claimants urged to take immediate action by visiting www.HepCclassaction.ca
TORONTO, Jan. 31,
2018 /CNW/ - A decades-long fight to compensate thousands of Canadians who were infected with hepatitis C from receiving blood transfusions or blood products between January 1, 1986 and July
The Courts have recently approved a compensation plan providing for approximately $40 million to be distributed to eligible victims who did not claim before the initial deadline – the original settlement program was approved in 1999 – due to matters beyond their control or where there is otherwise a reasonable explanation for their delay.
Anyone who believes they or a member of their family contracted hepatitis C from receiving blood or blood products in Canada during this period are encouraged to visit www.HepCclassaction.ca to find out more about the application process.
"Our goal is to ensure that all eligible victims are compensated," said Kathryn Podrebarac, one of the lawyers who sits on the Joint Committee which oversees the administration of the 1986-1990 Hepatitis C Settlement Agreement. "We will guide them on the steps they need to take to start the application process, because the sooner they do this, the sooner they can collect any compensation they may be entitled to."
This settlement provides compensation tailored to the victim's circumstances. Victims may be entitled to initial compensation ranging from $14,600 to $329,000, tax-free, and possibly additional compensation depending on their health and circumstances.
Hepatitis C is a progressive chronic disease that attacks liver cells and causes liver inflammation. A person infected with hepatitis C may not have symptoms for decades, and the virus may be transmitted from human to human.
The most common symptoms linked to the hepatitis C virus are:
Anyone concerned about hepatitis C should consult their doctor.
Potential claimants are urged to visit www.HepCclassaction.ca or call 1-866-353-4003 for additional information about the application process and the compensation available. Claimants have until March 31, 2025 to begin the application process.
SOURCE Hepatitis C Class Action
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All